Hyperbaric oxygen therapy, or HBOT, means breathing close to 100 % oxygen in a chamber pressurised above sea-level pressure. In hospitals it is an established treatment for conditions such as decompression sickness and wounds that won't heal. Some hair clinics sell it as an add-on after surgery. The idea is that extra oxygen may support healing during the days when the grafts have no blood supply of their own.
Research on this use is limited, but for the first few days it points the same way. In a randomised trial of 34 patients, less hair fell out in the first weeks. In a prospective observational study of 220 FUE patients, published in 2026, the scalp healed better, pain was lower and sleep was better. Both have weaknesses, and the number of grafts that grew at 12 months has never been measured. At best it helps healing. It doesn't give you new hair. Below you get both sides.
- Real HBOT needs both pressure and pure oxygen. A soft chamber, which typically reaches about 1.3 ATA, is not the treatment the researchers tested.
- The findings concern comfort and early healing: less shedding, itching and pain, and better sleep.
- Nobody has measured whether more grafts grow by 12 months.
- Safety is good with proper screening. The most common problem is pressure in the ears.
- Use after a hair transplant is not among the approved indications, so you pay for it yourself.
What is HBOT, and what happens during a session?
You breathe close to 100 % oxygen in a chamber where the pressure is higher than at sea level, and it has to be both: oxygen without pressure, or pressure without oxygen, doesn't count as HBOT. The hair transplant studies used a pressure of 2.0 to 2.4 atmospheres absolute (ATA), with sessions lasting 60 to 90 minutes. Either you lie alone in a small chamber or you sit with others in a larger one, and you have to equalise your ears as the pressure rises.

Pressure at sea level is one atmosphere absolute. The pressure in the studies, 2.0 to 2.4 ATA, is roughly what a diver feels at a depth of 10 to 14 metres. It takes a few minutes to raise the pressure and a few minutes to lower it again, and your ears feel it much as they do when a plane descends to land.
A single-person chamber is a closed cylinder you lie in. A multiplace chamber is a small room where several people sit together and breathe through a mask or hood. Most people find the latter easier to tolerate.
Soft, inflatable chambers sold as "mild hyperbaric" usually reach about 1.3 ATA, and many of them run on an oxygen concentrator rather than pure oxygen. None of the hair transplant studies used such a chamber, so their results say nothing about what a soft chamber does.
Why would more oxygen help the scalp heal?
For the first few days a newly placed graft has no blood vessels of its own and survives on oxygen that seeps in from the surrounding tissue. Under pressure, far more oxygen dissolves in the blood plasma, and it reaches tissue that red blood cells can't. The treatment also affects inflammation and how new blood vessels form. The logic holds up, but it is a reason to do research, not proof that it works.
At sea level almost all the oxygen in your blood is bound to haemoglobin, which is already about 97 % saturated. Breathing in more therefore adds little. Oxygen dissolved in plasma, on the other hand, rises with pressure, and it can get through swelling or across a gap where small blood vessels haven't grown in yet.
In a review article (Plastic and Reconstructive Surgery), Thom writes that hyperbaric oxygen acts less as an oxygen delivery and more as a signal, carried by reactive oxygen and nitrogen species. Systematic reviews and randomised trials support the treatment for diabetic wounds that won't heal and for damage after radiotherapy. For skin grafts and flaps with poor blood supply, the closest thing we have to a hair transplant, the support rests on animal studies and a small number of clinical studies.
A placed follicular unit is, in a narrow sense, a tiny free graft. The comparison is reasonable. But it is only a comparison.
What have studies of HBOT after a hair transplant found?
The findings are few and small, but for the first days they point the same way. A randomised trial of 34 patients published in 2021 found that fewer lost hair early and fewer developed itching or folliculitis. In a prospective observational study of 220 FUE patients published in 2026, those who had HBOT slept better, had less pain and rated their own healing as better, and a blinded photo assessment pointed the same way. Nobody has measured whether HBOT leads to more grafts growing by 12 months.
As of September 2026 there are four studies relevant to the question. They are designed so differently that each deserves its own description.
The randomised trial, 34 patients. Fan and co-authors published in 2021 in the Journal of Cosmetic Dermatology. The FUE patients were split into two groups. 17 breathed 100 % oxygen for one hour a day (60 minutes, 2.0 ATA) for seven days. The other 17 had no HBOT.
| Outcome measured | With HBOT | Without HBOT |
|---|---|---|
| Early shedding | 27.6 % | 69.1 % |
| Itching or folliculitis | 11.8 % | 35.3 % |
| Graft survival at nine months | 96.9 % | 93.8 % |
The difference in survival was not statistically significant.
The cohort, 220 patients. This prospective observational study from 2026 of 220 men who had FUE was carried out and published by a clinic we cover on this site. Patients had either no HBOT (55), one session (97) or two sessions (68) in a hard-shell chamber, 90 minutes per session at a pressure of 2.4 ATA. The same surgeon operated on everyone, with the same technique and the same aftercare. On day 11 the patients rated their own improvement on a scale up to 10, where higher is better. A medical team who didn't know which group each patient was in gave the day-10 photos a separate score.
| Score (out of 10) | No session | One session | Two sessions |
|---|---|---|---|
| Healing | 5.7 | 7.3 | 8.0 |
| Pain and tenderness | 4.3 | 7.8 | 8.8 |
| Sleep | 4.4 | 8.6 | 9.3 |
| Redness resolved | 3.8 | 5.2 | 5.7 |
| Blinded photo assessment | 5.3 | 8.6 | 9.7 |
Both HBOT groups scored significantly higher than the group without. Patients chose their own group and were not randomly assigned, so the finding shows an association and doesn't prove cause. The difference between one and two sessions was not significant.
The case report, 5 patients. In Cureus, Giardiello and co-authors in 2025 described five men who had one session a day for six days, 90 minutes at 2.4 ATA. The first started four to six hours after surgery. The crusts cleared within three to five days, and 97 to 99 % of grafts reportedly took. There was no control group.
The trial in 9 healthy volunteers. Lee and co-authors (Bioengineering, 2026) had participants complete 50 sessions over three months, all at 2.0 ATA. Follicle density, hair volume and the number of hairs per follicle rose slightly, but not significantly. None of the participants had had a transplant.
If your hair loss has only just started, a procedure may not be the right step yet. The medical team at the clinic at the top of our ranking can look at your photos and tell you honestly whether to wait, start with treatment or consider more.
Goes to the clinic at the top of our ranking.
Where does our knowledge of HBOT end?
It stops short of 12 months, and short of the question of cause. The randomised trial of 34 patients was too small to detect three percentage points in graft survival, the 220-patient cohort let people pick their own group, and nobody has counted grafts at 12 months. Sceptics dismiss small HBOT studies because of design weaknesses like these, not because the mechanism seems implausible.
Four weaknesses decide how much weight you can put on the results:
- Size. After a well-performed FUE most grafts already survive (93.8 % in the trial's control group), so an add-on has little room to work with. To detect two to three percentage points around 95 %, each group needs several hundred patients. The trial had 17. So the survival figures speak neither for nor against HBOT. What holds up best are the large differences in itching or folliculitis and in early shedding.
- Design. In the cohort, patients decided for themselves whether to have HBOT. That lets you see an association, not that the treatment is the cause. People with diabetes, treated high blood pressure, HIV or other serious illness were excluded, and the study says nothing about them.
- Measurement. Most of the cohort's measures were the patients' own ratings. That the blinded photo assessment agreed with them is the study's strongest point, but the photos were from day 10, not of the final result. None of the transplant studies had a control group with sham pressure treatment, so nobody knows how much of the effect came from the extra attention of turning up every day.
- Who ran the studies. The cohort was carried out and published by a clinic we cover on this site. Nobody else has repeated the design. In a letter to the editor, Dong and Jin pointed out that the randomised trial didn't clearly separate results by sex and didn't explain how the use of hair loss medication fitted into the exclusion criteria. Neither point has since been answered.
A firm answer would need a multicentre randomised trial with several hundred patients in each group, blinded hair counts in a marked area at 12 months and a control group with sham pressure treatment. Nobody can patent oxygen, so there is no obvious sponsor. The evidence may therefore stay where it is for quite some time.
Does HBOT reduce swelling or make healing easier?
What has been measured is comfort, not swelling. Fewer people developed itching and folliculitis in the randomised trial. In the 220-patient cohort, those who had HBOT had less pain, slept better and saw redness fade faster by day 11. Less swelling is the most heavily marketed benefit, but no study has reported swelling as a separate outcome.
The forehead and the area around the eyes swell most from day two to four. It comes mostly from the fluid injected during the procedure, and normal aftercare deals with it, partly by sleeping with your head raised for the first few nights.
In the cohort, swelling and oedema were among the things the blinded assessors looked for. Even so, each group got just one combined score, and no separate figure for swelling.
The comfort findings are more consistent. The biggest difference was in sleep: the group without HBOT scored 4.4 out of 10, the two-session group 9.3. In the randomised trial, itching and folliculitis fell to about a third. Remember that the cohort scores come from patients who chose the treatment themselves.
How many sessions did the studies use, and when?
Both published schedules started on the day of surgery or the day after and ran daily for six or seven days. The randomised trial used 60 minutes at 2.0 ATA, the five-patient report 90 minutes at 2.4 ATA. The 220-patient cohort gave one or two sessions, each 90 minutes at 2.4 ATA. Nobody has compared pressure, duration, start time or number of sessions, so no schedule is documented as the best.
The mechanism argues for starting early. The possible benefit applies to the days before the graft has its own blood supply. In the cohort, a second session gave no significant gain over one. Three things go beyond the studies:
- Waiting until at least a week has passed before the first session, or starting when hair falls out between weeks 2 and 3. That shedding is part of the normal hair cycle and isn't caused by a lack of oxygen.
- Courses of fifteen sessions or more, or so-called maintenance programmes. The only long course anyone has studied was 50 sessions in healthy volunteers without a transplant.
- Sessions that last longer, or pressure that is higher, than in the studies.
Practical matters also affect timing. A large FUE procedure can take six to eight hours. If you've been sedated, the first session may be moved to the next day, because you need to be clear-headed enough to equalise your ears. And with a daily course you can't travel anywhere that week. We describe what has been studied and give no dosing recommendation. Your surgeon and the hyperbaric unit decide the schedule.
What are the risks of HBOT, and who shouldn't have it?
With proper screening, HBOT is very safe. Pressure injury to the middle ear (barotrauma) is the most common side effect, and the rest mostly involves pressure injury to the sinuses, temporary short-sightedness after many sessions, fear of confined spaces and, rarely, seizures from too much oxygen. An untreated collapsed lung (pneumothorax) is the only thing universally regarded as an absolute bar, while a range of other conditions need assessment by a doctor in hyperbaric medicine first.
Heyboer and co-authors review the side effects in Advances in Wound Care and place HBOT among the safest treatments we have. Side effects do occur, but they are largely dose-related.
- Ears and sinuses. If you can't equalise, the eardrum is pulled inwards. It hurts and can sometimes cause fluid, bleeding or a perforated eardrum. A blocked nose, a cold, hay fever and recent ear surgery make it more likely. The sinuses can suffer the same injury.
- Too much oxygen. At high pressure and long times in the chamber, seizures can rarely occur. They pass on their own, and that is why every schedule states pressure and duration. Effects on the lungs are mainly a concern with long, daily courses.
- Vision and comfort. Many sessions can cause short-sightedness that wears off again. Many people stop because they can't tolerate confined spaces, and since the treatment is optional, stopping is completely fine.
If you have obstructive lung disease, recent ear, sinus or chest surgery, a condition that causes seizures, a respiratory infection, a high fever, certain types of chemotherapy, an implanted device or are pregnant, a doctor in hyperbaric medicine should assess you, not the hair surgeon. Tell the hyperbaric unit about every medicine you take, including finasteride and dutasteride, and oral minoxidil. Expect a screening before you pay for a course.
Who might benefit from HBOT, and does it apply to smokers and people with diabetes?
What little evidence exists favours you if you want the first two weeks to be a bit easier, can attend every day and pass the screening. Smokers and people with diabetes are often mentioned, since both groups heal less well. But none of the hair transplant studies included them or looked at them separately, so the idea that they would benefit is an assumption.
It may make sense if you've had troublesome folliculitis before, dread the shedding phase or will be near a hyperbaric centre anyway. The case is weak if you fly home a few days after surgery, don't like enclosed spaces, or would rather put the money towards keeping the hair you have left.
Smoking. Nicotine constricts the small blood vessels, and carbon monoxide means the blood can carry less oxygen. This happens exactly when the grafts depend on oxygen seeping in. Dissolved oxygen doesn't need haemoglobin, so it is logical to think HBOT might offset some of this. It just hasn't been tested. Stopping smoking for the period your surgeon asks has good support and costs you nothing. If HBOT is the argument for giving a smoker a larger, denser procedure, that is a sales pitch with risk attached.
Diabetes. The strongest evidence for HBOT concerns diabetic wounds that won't heal, such as foot ulcers and other chronic wounds in tissue where the small blood vessels are already damaged. A hair transplant in someone with well-controlled diabetes is a planned wound in a scalp with a good blood supply. The evidence can't simply be carried over, and the cohort excluded people with diabetes. Good blood sugar control and a cautious surgical plan have support. Discuss chamber sessions with both the clinic and the team who look after your diabetes.
Large procedures. No hair transplant study has looked at HBOT for preventing tissue death in the recipient area. It should therefore not influence how large or dense your surgeon thinks a procedure can safely be.
Is HBOT a better add-on than PRP or LLLT?
They target different problems at different times. HBOT concerns the first weeks of healing and is given as a one-week course, while research on PRP and LLLT mostly concerns hair thinning over months. That research is larger, but it is about androgenetic alopecia, not about protecting new grafts. Not one of the three has shown that more transplanted follicles grow.
- Commitment. HBOT means turning up at the chamber every day for about a week. PRP means a blood draw and injections into the scalp, with repeat rounds over several months. LLLT, low-level laser and light therapy, is usually a device you use at home for a few minutes at a time over months.
- Research. For hereditary hair loss there are randomised trials and meta-analyses of both PRP and low-level laser, with known weaknesses. Research on HBOT for transplants is far smaller, but it asks the right question: how you recover after surgery.
- What is being protected. A transplant moves follicles. It doesn't stop ongoing hair loss. HBOT doesn't help the original hair between and around the grafts. That is where PRP and LLLT have their studies.
- Combinations. Nobody has tested HBOT together with PRP, LLLT or exosomes after a transplant. A package of several of them has never been evaluated.
If you want an add-on, choose one, insist on a separate price for it, and have the established medicines in place first.
What should the clinic answer before you pay for HBOT?
Ask how high the chamber pressure goes and whether you breathe pure oxygen, who runs the chamber and screens you beforehand, how many sessions you get and why, what it costs on top of surgery, and what the clinic expects it to do for you. HBOT is not approved for use with hair transplants, so after surgery it is off-label, and the bill is yours.
Six questions to take with you:
- How many ATA does the chamber reach, and do I breathe pure 100 % oxygen or air from a concentrator? A soft chamber at about 1.3 ATA is not the treatment that has been studied.
- Is it a hard-shell chamber with staff trained in hyperbaric medicine? Is it at your clinic or somewhere else, and who screens me for contraindications before I pay?
- How many sessions, on which days, and why exactly that? No published schedule supports fifteen sessions or maintenance.
- What does each session and the whole course cost? Is it priced separately from the surgery, does the price go down if I say no, and do I get a refund if I can't tolerate the chamber?
- What do you think it will do for me, and which study is that based on? Were the participants transplant patients, or was it about something else?
- Which proven treatment do I get first, and what is this supposed to add on top?
Very few hair clinics have their own hard-shell chamber. Many refer you to an outside centre, and some describe a soft chamber as if it were the same thing. Hair transplants are not on the list of approved indications from the professional body Undersea and Hyperbaric Medical Society, so neither insurance nor the public health system can be expected to pay. We don't give prices, since we haven't found verifiable published prices for HBOT after a transplant. If a clinic promises more hair at 12 months, it is promising something that has never been measured.
What people ask about HBOT
What does hyperbaric oxygen therapy mean?
You breathe close to 100 % oxygen in a chamber pressurised above sea level. The hair transplant studies used 2.0 to 2.4 ATA, with sessions of 60 to 90 minutes. You need both the pressure and the oxygen. Oxygen through a mask at normal pressure is not HBOT.
Is HBOT approved as a treatment after a hair transplant?
No. Hair transplants are missing from the Undersea and Hyperbaric Medical Society list of approved indications. HBOT after surgery is therefore off-label and something you pay for yourself. That says something about rules and who pays, not about whether the treatment works.
Does transplanted hair grow better with HBOT?
Nobody knows. No study has counted grafts or measured density at 12 months. In the randomised trial, 96.9 % of grafts survived at nine months in the HBOT group versus 93.8 % in the group without, and with 34 patients the difference was not statistically significant.
Does the scalp heal faster, or is there less swelling?
What has been found is fewer people losing hair early, fewer with itching and folliculitis, less pain, better sleep and faster improvement in redness. Swelling was not measured separately, and the cohort with the best comfort figures was an observational study.
How many sessions did participants have in the studies?
In the randomised trial they had seven daily sessions of 60 minutes at 2.0 ATA, and in the five-patient report six daily sessions of 90 minutes at 2.4 ATA. The 220-patient cohort compared zero, one and two sessions, with no significant gain from a second session. Since nobody has compared schedules, there is no documented right number.
Is HBOT dangerous or painful?
With proper screening it is safe, and the sessions don't hurt. The most common problem is ear pain from the pressure (middle-ear barotrauma) if you can't equalise. Sinus pain, temporary short-sightedness, claustrophobia and, rarely, seizures from too much oxygen also occur.
Do smokers or people with diabetes benefit more from HBOT?
It hasn't been tested. None of the hair transplant studies included or analysed them separately, and people with diabetes were excluded from the 220-patient cohort. Stopping smoking and good blood sugar control are the measures that actually have support.
Does a soft "mild hyperbaric" chamber have the same effect?
No. Soft chambers usually reach about 1.3 ATA, and many run on a concentrator. The researchers used hard chambers, pure oxygen and pressures of 2.0 to 2.4 ATA, so the results can't be applied to a soft chamber.
Should I choose HBOT over PRP or LLLT?
They solve different problems. HBOT is a one-week course aimed at initial healing, while research on PRP and LLLT concerns hair thinning over months. None of the studies we cover has compared them head to head after a transplant.
Can HBOT bring my hair back or replace medication?
No. HBOT targets healing after surgery and doesn't revive follicles that are gone. Ongoing hair loss also continues after a transplant. Finasteride and minoxidil remain the foundation for the hair you have left.
Choose your surgeon and method first. HBOT is an optional add-on, and the most it can offer is an easier first fortnight. It doesn't replace good surgery, careful aftercare or the treatments that protect the hair you still have, and follicles that are gone won't come back. A free hair analysis tells you what is causing your hair loss and whether any extra treatment is relevant for you at all, before the money is spent.
This is general information and not medical advice. Whether HBOT is safe for you is for a doctor trained in hyperbaric medicine to decide.
Goes to the clinic at the top of our ranking.
Sist oppdatert: October 2026 · Redaksjonelle standarder
